Archive - April 2025
Sanofi Advances Mid- to Late-Stage Respiratory Pipeline, Targeting Unmet Need in Asthma, COPD
STAT+: Bristol’s Cobenfy disappoints as supplemental antipsychotic drug
Chrissy Teigen Joins Sanofi Campaign for Early Diabetes Testing
Pharmaceutical Compounding Calculations, Part One–Non-Salts, Salts, and Policy-Exception Salts
Court Rejects Challenge to DEA ALJ Hearing Authority Over Removal Power
Understanding Chronic Inflammation Through Viral Exposure
Food companies agree to phase out synthetic dyes, handing MAHA a victory
Bavarian Nordic Chikungunya Vaccine Recommended by CDC’s ACIP